跳至主要内容
临床试验/NCT01163994
NCT01163994Unknown不适用

Comparison of Ceftriaxone and Doxycycline for Treatment of Multiple Erythema Migrans

University Medical Centre Ljubljana1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
500
试验地点
1
主要终点
Objective sequelae and post-treatment subjective symptoms such as fatigue, malaise, arthralgias, headache, myalgias, paresthesias, dizziness, or irritability in patients treated for multiple erythema migrans with ceftriaxone or doxycycline for 15 days.

研究概览

简要总结

The purpose of this study is to compare the efficacy and safety of 15-day ceftriaxone versus 15-day doxycycline treatment in patients with multiple erythema migrans.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
15 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • multiple erythema migrans in patients > 15 years

排除标准

  • a history of Lyme borreliosis in the past
  • pregnancy or lactation
  • immunocompromised status
  • serious adverse event to doxycycline or beta lactam antibiotic
  • taking antibiotic with antiborrelial activity within 10 days

研究组 & 干预措施

MEM-ceftriaxone

Active Comparator

干预措施: ceftriaxone (Drug)

MEM-doxycycline

Active Comparator

干预措施: doxycycline (Drug)

EM-doxycycline

Active Comparator

干预措施: erythema migrans patients treated with doxycycline (Other)

结局指标

主要结局

Objective sequelae and post-treatment subjective symptoms such as fatigue, malaise, arthralgias, headache, myalgias, paresthesias, dizziness, or irritability in patients treated for multiple erythema migrans with ceftriaxone or doxycycline for 15 days.

时间窗: fifth assessment at 12 months postenrollment

次要结局

  • Objective sequelae and post-treatment subjective symptoms such as fatigue, malaise, arthralgias, headache, myalgias, paresthesias, dizziness, or irritability in patients with solitary versus multiple erythema migrans after antibiotic treatment.(fifth assessment at 12 months postenrollment)
  • Comparison of subjective symptoms such as fatigue, malaise, arthralgias, headache, myalgias, paresthesias, or irritability between patients treated with antibiotic for multiple erythema migrans and control subjects without a history of Lyme borreliosis.(third assessment at 6 months postenrollment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Franc Strle

M.D., PhD

University Medical Centre Ljubljana

研究点 (1)

Loading locations...

相似试验